BioNTech (Germany) Market Value
| 22UA Stock | 108.70 1.30 1.18% |
| Symbol | BioNTech |
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 01/13/2023 |
| 01/02/2025 |
If you would invest 0.00 in BioNTech on January 13, 2023 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 720 days. BioNTech is related to or competes with Methode Electronics, SINGAPORE AIRLINES, JAPAN AIRLINES, Electronic Arts, KIMBALL ELECTRONICS, ARROW ELECTRONICS, and UET United. More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.98 | |||
| Information Ratio | 0.0217 | |||
| Maximum Drawdown | 16.83 | |||
| Value At Risk | (3.91) | |||
| Potential Upside | 3.84 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0277 | |||
| Jensen Alpha | 0.0622 | |||
| Total Risk Alpha | 0.059 | |||
| Sortino Ratio | 0.0205 | |||
| Treynor Ratio | (0.19) |
BioNTech SE Backtested Returns
At this point, BioNTech is very steady. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0066, which signifies that the company had a 0.0066% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please confirm BioNTech's Downside Deviation of 2.98, risk adjusted performance of 0.0277, and Mean Deviation of 1.84 to double-check if the risk estimate we provide is consistent with the expected return of 0.0193%. The firm shows a Beta (market volatility) of -0.32, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioNTech are expected to decrease at a much lower rate. During the bear market, BioNTech is likely to outperform the market. BioNTech SE right now shows a risk of 2.91%. Please confirm BioNTech SE downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if BioNTech SE will be following its price patterns.
Auto-correlation | -0.31 |
Poor reverse predictability
BioNTech SE has poor reverse predictability. Overlapping area represents the amount of predictability between BioNTech time series from 13th of January 2023 to 8th of January 2024 and 8th of January 2024 to 2nd of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 144.21 |
BioNTech SE lagged returns against current returns
Autocorrelation, which is BioNTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioNTech's stock expected returns. We can calculate the autocorrelation of BioNTech returns to help us make a trade decision. For example, suppose you find that BioNTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioNTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioNTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioNTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioNTech stock over time.
Current vs Lagged Prices |
| Timeline |
BioNTech Lagged Returns
When evaluating BioNTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioNTech stock have on its future price. BioNTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioNTech autocorrelation shows the relationship between BioNTech stock current value and its past values and can show if there is a momentum factor associated with investing in BioNTech SE.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Additional Information and Resources on Investing in BioNTech Stock
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:Check out BioNTech Correlation, BioNTech Volatility and BioNTech Alpha and Beta module to complement your research on BioNTech. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.